Tag: Phase 3 Clinical Trial

December 11, 2019

MacroGenics Presents Results from SOPHIA Study

The company reported results from its Phase 3 SOPHIA study in patients with HER2-positive metastatic breast cancer.
December 9, 2019

Abeona Therapeutics to Initiate Phase 3 Clinical Trial of B-101

The company announced that the US Food and Drug Administration has removed its clinical hold on its Phase 3 clinical...
December 9, 2019

Ocugen Completes 50 Percent Enrollment in Phase 3 Clinical Trial

The company announced 50 percent of enrollment in its Phase 3 clinical trial for OCU300 has been completed.
November 26, 2019

Acasti Pharma Updates on TRILOGY 1 Phase 3 Trial

The company announced that the last patient completed their final visit in its TRILOGY 1 pivotal Phase 3 clinical trial...
November 25, 2019

Avadel Pharma Reaches Enrollment Target in REST-ON Trial

The company announced that its Phase 3 REST-ON Phase 3 trial has enrolled 205 patients who have narcolepsy and cataplexy,...
November 21, 2019

Tonix Pharmaceuticals Begins Phase 3 RELIEF Study

The company announced that its Phase 3 RELIEF Study will evaluate its TNX-102- SL in patients with fibromyalgia.
November 20, 2019

Alnylam Gets FDA Nod for Rare Disease Drug

The FDA's approval of Alnylam's Gilvaari treatment is the first approval of its kind for acute hepatic porphyria.